NCT07140900 · Interventional trial
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
Overall registry status Active not recruiting
Phase 1
Conditions Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Delaware Valley sites
- Thomas Jefferson University · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory